Related Experiment Video
Updated: May 27, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Evaluation of chronic diarrhea
Gregory Juckett1, Rupal Trivedi
1West Virginia University, Morgantown, USA. gjuckett@hsc.wvu.edu
Chronic diarrhea, lasting over four weeks, is categorized as watery, fatty (malabsorption), or inflammatory. Effective diagnosis involves classifying the diarrhea type to guide targeted testing and treatment strategies.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Chronic diarrhea is a prevalent and complex clinical condition.
- It significantly impacts patient quality of life and healthcare resource utilization.
Purpose of the Study:
- To outline a practical diagnostic approach for chronic diarrhea.
- To categorize chronic diarrhea into distinct types for effective management.
Main Methods:
- Classification of chronic diarrhea into watery, fatty (malabsorption), and inflammatory subtypes.
- Subdivision of watery diarrhea into osmotic, secretory, and functional categories.
- Identification of key indicators for each diarrhea type, such as irritable bowel syndrome, microscopic colitis, celiac disease, and inflammatory bowel disease.
Main Results:
- Watery diarrhea encompasses functional (e.g., irritable bowel syndrome) and secretory (e.g., microscopic colitis) types.
- Malabsorptive diarrhea presents with steatorrhea or weight loss, with examples including celiac disease and giardiasis.
- Inflammatory diarrhea is marked by blood/pus in stool and elevated fecal calprotectin, often due to infections or inflammatory bowel diseases like ulcerative colitis and Crohn disease.
Conclusions:
- Categorizing chronic diarrhea by type is crucial for efficient diagnosis and treatment.
- This approach narrows diagnostic possibilities, reduces unnecessary investigations, and allows for targeted empiric therapy when appropriate.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...

